Paradromics develops fully implantable brain–computer interface systems designed to restore communication for individuals with paralysis. The company’s flagship platform, Connexus, focuses on recording high-resolution neural activity directly from the brain. Its approach emphasizes high data throughput and scalability to support complex neural decoding. Paradromics positions its technology within regulated clinical development pathways.

The technology records single-neuron activity using implantable electrode arrays designed for chronic use. These neural signals are transmitted at high data rates to external processing systems, where decoding algorithms translate brain activity into communication outputs. The system is engineered to support stable, long-term recording while minimizing signal loss. This architecture prioritizes bandwidth and fidelity to enable more expressive and reliable neural interfaces.

Paradromics targets patients with severe paralysis who require assistive communication technologies. The Connexus system is intended for use within clinical research and therapeutic deployment under professional supervision. Its positioning reflects broader efforts to advance intracortical BCIs toward practical, high-performance systems capable of supporting real-world communication needs.